Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Center
Clinical trial register · Turkey

Clinical Trials in Center, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Center

13 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
AstraZeneca
Phase 3
500
Ankara, Antalya, Center, Istanbul
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Adana, Ankara, Antalya, Center, Istanbul, Izmir, Kahramanmaraş, Kütahya
2026-08-24
Active, closed
Home Visit Simulation-based Earthquake Preparedness Training for Nursing Students
NCT07712185Communication Skills, Self Directed Learning, Earthquake
Duzce University
Not applicable
39
Center
2026-05-04
Recruiting
Kirsehir Ahi Evran Universitesi
Not applicable
40
Center
2026-02-23
Recruiting
Kirsehir Ahi Evran Universitesi
Not applicable
60
Center
2026-01-19
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Altındağ, Ankara, Center, Istanbul, Kocaeli
2025-11-26
Recruiting
Kirsehir Ahi Evran Universitesi
Not applicable
50
Center
2025-11-20
Recruiting
AstraZeneca
Phase 3
3,850
Adana, Ankara, Antalya, Bursa, Center, Dinar, Eskişehir, Istanbul
2024-04-12
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc.
Phase 3
1,350
Adana, Ankara, Bursa, Center, Fatih, Gaziantep, Istanbul, Izmir
2024-03-13
Active, closed
AstraZeneca
Phase 3
314
Ankara, Antalya, Center, Kazımkarabekir, Kocaeli
2023-11-08
Active, closed
Areteia Therapeutics
Phase 3
600
Adana, Ankara, Antalya, Bornova, Center, Istanbul, Konak, Mersin
2023-01-30
Active, closed
Incyte Corporation
Phase 3
82
Ankara, Center, Istanbul, Izmir, Kayseri, Mersin, Yenimahalle
2022-12-23
Active, closed
Hoffmann-La Roche
Phase 3
769
Ankara, Center, Çankaya, Istanbul, Kayseri, Kocaeli, Lzmir, Mersin
2020-12-03
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/center

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies with a site in Center.

How many clinical trials are recruiting in Center?

8 of the 13 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Center), 13 studies
PhaseStudiesRecruitingShare
Phase 38461.5%
Not applicable4330.8%
Phase 2117.7%

Most active sponsors

Lead sponsors with the most studies (Center)
Lead sponsorStudiesRecruiting
AstraZeneca43
Kirsehir Ahi Evran Universitesi33
89bio, Inc.11
Alexion Pharmaceuticals, Inc.11
Areteia Therapeutics10
Duzce University10
Hoffmann-La Roche10
Incyte Corporation10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.